InO induces DNA DSBs. Leukemic B-cells can resist InO by harboring alteration of DSB transducers, alteration of BCL2 pathway, reduced CD22 expression or immunogenicity secondary to hypermutations, and finally by lowering DNTT expression to attenuate InO-induced DNA damage.